Salarius Pharmaceuticals
SLRX
SLRX
10 hedge funds and large institutions have $227K invested in Salarius Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Holders
10
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$75.9K | |
| 2 | +$5.41K | |
| 3 | +$2.39K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$2.15K |
Top Sellers
| 1 | -$1.49K | |
| 2 | -$473 | |
| 3 | -$79 | |
| 4 |
BlackRock
New York
|
-$70 |
| 5 |
Wells Fargo
San Francisco,
California
|
-$25 |